Deloitte: Life Science should move into other emerging markets
Deloitte believes that an increased focus on other emerging markets than the BRIC countries would be a sound move for Danish companies in the Life Science industry.
Life Science companies should bear in mind that there are other emerging markets than the BRIC countries and make sure they are locally present, if they want to succeed, says the professional services firm Deloitte.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
